stock-detail (Kolltan)

Oncology Corporate Profile

Company Description

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
KTN-3379anti-erbb3 monoclonal antibodyVarious cancer typesI

Recent News Headlines

There are no news items to display